References
- Ejerblad E, Fored CM, Lindblad P, et al. Obesity and risk for chronic renal failure. J Am Soc Nephrol 2006;17:1695–702
- Sato E, Mori T, Nakamichi Y, Fujiwara M, et al. Role of renin-angiotensin system, oxidative stress and inflammation to the blood pressure control in young subjects. XVI International Congress on Nutrition and Metabolism in Renal Disease ICRNM, Honolulu, Hawaii, June 26–30, 2012, 53–60
- Kobori H, Alper AB, Jr Shenava R, et al. Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients. Hypertension 2009;53:344–50
- Shatat IF, Flynn JT. Relationships between renin, aldosterone, and 24-hour ambulatory blood pressure in obese adolescents. Pediatr Res 2011;69:336–40
- Thethi TK KH, Yau CL, Ali S, et al. Gender differences in urinary angiotensinogen in obese individuals without diabetes mellitus. Hypertension 2010;56:e100
- Ikawa T, Ikeda M, Yamaguchi A, Tsai WC, et al. Expression of arthritis-causing HLA-B27 on Hela cells promotes induction of c-fos in response to in vitro invasion by Salmonella typhimurium. J Clin Invest 1998;101:263–72
- Katsurada A, Hagiwara Y, Miyashita K, et al. Novel sandwich ELISA for human angiotensinogen. Am J Physiol Renal Physiol 2007;293:F956–60
- Rahman M, Kimura S, Nishiyama A, et al. Angiotensin II stimulates superoxide production via both angiotensin AT1A and AT1B receptors in mouse aorta and heart. Eur J Pharmacol 2004;485:243–9
- Kawano Y, Tsuchihashi T, Matsuura H, et al. Report of the Working Group for Dietary Salt Reduction of the Japanese Society of Hypertension: assessment of salt intake in the management of hypertension. Hypertens Res 2007;30:887–93
- Inayama T, Higuchi Y, Tsunoda N, et al. Associations between abdominal visceral fat and surrogate measures of obesity in Japanese men with spinal cord injury. Spinal Cord 2014;52:836–41
- Kadota A, Miura K, Okamura T, et al. Relationship of moderate metabolic risk factor clustering to cardiovascular disease mortality in non-lean Japanese: a 15-year follow-up of NIPPON DATA90. Atherosclerosis 2011;215:209–13
- Matsuzawa Y, Funahashi T, Nakamura T. The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. J Atheroscler Thromb 2011;18:629–39
- Kang YS. Obesity associated hypertension: new insights into mechanism. Electrolyte Blood Pres. 2013;11:46–52
- Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114:1752–61
- Andersen KK, Andersen ZJ, Olsen TS. Age- and gender-specific prevalence of cardiovascular risk factors in 40,102 patients with first-ever ischemic stroke: a Nationwide Danish Study. Stroke 2010;41:2768–74
- Kobori H, Ohashi N, Katsurada A, et al. Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases. J Am Soc Hypertens 2008;2:349–54
- Urushihara M, Kondo S, Kagami S, Kobori H. Urinary angiotensinogen accurately reflects intrarenal renin-angiotensin system activity. Am J Nephrol 2010;31:318–25
- Soltysiak J, Skowronska B, Fichna P, et al. Urinary angiotensinogen and urinary sodium are associated with blood pressure in normoalbuminuric children with diabetes. Pediatr Nephrol 2014;29:2373–8
- Ogawa S, Kobori H, Ohashi N, et al. Angiotensin II type 1 receptor blockers reduce urinary angiotensinogen excretion and the levels of urinary markers of oxidative stress and inflammation in patients with type 2 diabetic nephropathy. Biomark Insights 2009;4:97–102
- Mori T, Cowley AW, Jr. Role of pressure in angiotensin II-induced renal injury: chronic servo-control of renal perfusion pressure in rats. Hypertension 2004;43:752–9
- Makino A, Skelton MM, Zou AP, et al. Increased renal medullary oxidative stress produces hypertension. Hypertension 2002;39:667–72
- De Miguel C, Guo C, Lund H, et al. Infiltrating T lymphocytes in the kidney increase oxidative stress and participate in the development of hypertension and renal disease. Am J Physiol Renal Physiol 2011;300:F734–42
- Kurukulasuriya LR, Stas S, Lastra G, et al. Hypertension in obesity. Med Clin North Am 2011;95:903–17
- Sowers JR. Diabetes mellitus and vascular disease. Hypertension 2013;61:943–7
- Ross EA. Congestive renal failure: the pathophysiology and treatment of renal venous hypertension. J Card Fail 2012;18:930–8
- Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378–84